Zhi‐Han Tang

1.9k total citations
37 papers, 1.5k citations indexed

About

Zhi‐Han Tang is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Zhi‐Han Tang has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 14 papers in Molecular Biology and 7 papers in Biochemistry. Recurrent topics in Zhi‐Han Tang's work include Lipoproteins and Cardiovascular Health (12 papers), Sulfur Compounds in Biology (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Zhi‐Han Tang is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Sulfur Compounds in Biology (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Zhi‐Han Tang collaborates with scholars based in China, Canada and United States. Zhi‐Han Tang's co-authors include Zhong Ren, Zhi‐Sheng Jiang, Juan Peng, Lushan Liu, Mi‐Hua Liu, Dangheng Wei, Lihong Pan, Lu-Shan Liu, Shun-Lin Qu and Zhisheng Jiang and has published in prestigious journals such as Molecular and Cellular Biology, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Zhi‐Han Tang

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi‐Han Tang China 22 579 446 289 253 237 37 1.5k
Denis Féliers United States 31 335 0.6× 1.2k 2.8× 292 1.0× 362 1.4× 351 1.5× 57 2.4k
Zhisheng Jiang China 25 438 0.8× 778 1.7× 318 1.1× 143 0.6× 85 0.4× 85 1.8k
Alexander Akhmedov Switzerland 25 400 0.7× 686 1.5× 472 1.6× 307 1.2× 76 0.3× 49 2.0k
Dongming Su China 21 424 0.7× 911 2.0× 108 0.4× 262 1.0× 97 0.4× 49 1.8k
Stephen L. Pinkosky United States 15 617 1.1× 754 1.7× 126 0.4× 240 0.9× 89 0.4× 19 1.6k
Kazuhiro Sonoda Japan 14 263 0.5× 784 1.8× 194 0.7× 416 1.6× 98 0.4× 17 1.7k
Jun Kusunoki Japan 18 475 0.8× 631 1.4× 121 0.4× 267 1.1× 139 0.6× 30 1.4k
Eseng Lai United States 20 410 0.7× 474 1.1× 104 0.4× 182 0.7× 76 0.3× 60 1.8k
David G. Hassall United Kingdom 21 560 1.0× 777 1.7× 253 0.9× 512 2.0× 165 0.7× 34 2.1k
Lushan Liu China 19 607 1.0× 460 1.0× 402 1.4× 165 0.7× 66 0.3× 36 1.4k

Countries citing papers authored by Zhi‐Han Tang

Since Specialization
Citations

This map shows the geographic impact of Zhi‐Han Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Han Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Han Tang more than expected).

Fields of papers citing papers by Zhi‐Han Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Han Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Han Tang. The network helps show where Zhi‐Han Tang may publish in the future.

Co-authorship network of co-authors of Zhi‐Han Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Han Tang. A scholar is included among the top collaborators of Zhi‐Han Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Han Tang. Zhi‐Han Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanxia, Hongyu Zheng, Hongyu Zheng, et al.. (2024). Hydrogen sulfide upregulates SIRT1 to inhibit ox-HDL-induced endothelial cell damage and mitochondrial dysfunction. Nitric Oxide. 152. 78–89. 5 indexed citations
2.
Wang, Jinyuan, Min Luo, Ge Tian, et al.. (2022). Effect of spermidine on ameliorating spermatogenic disorders in diabetic mice via regulating glycolysis pathway. Reproductive Biology and Endocrinology. 20(1). 45–45. 21 indexed citations
3.
Hu, Heng-Jing, et al.. (2021). Hydrogen sulfide improves ox‑LDL‑induced expression levels of Lp‑PLA2 in THP‑1 monocytes via the p38MAPK pathway. Molecular Medicine Reports. 23(5). 6 indexed citations
4.
Ren, Zhong, Juan Peng, Yaling Tang, et al.. (2020). Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab. Current Medicinal Chemistry. 28(5). 1025–1041. 14 indexed citations
5.
Feng, Shujun, et al.. (2019). Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease. Chinese Journal of Natural Medicines. 17(1). 50–58. 7 indexed citations
6.
Hao, Yameng, et al.. (2019). Tissue factor pathway inhibitor in atherosclerosis. Clinica Chimica Acta. 491. 97–102. 12 indexed citations
7.
Cao, Jianping, Yaling Tang, Wenhao Xiong, et al.. (2019). PCSK9: A new participant in lipophagy in regulating atherosclerosis?. Clinica Chimica Acta. 495. 358–364. 13 indexed citations
8.
Hu, Heng-Jing, Chi Zhang, Zhi‐Han Tang, Shun-Lin Qu, & Zhi‐Sheng Jiang. (2019). Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation. Biochemical and Biophysical Research Communications. 516(3). 653–660. 25 indexed citations
9.
Lin, Xiaolong, et al.. (2018). Role of PCSK9 in lipid metabolism and atherosclerosis. Biomedicine & Pharmacotherapy. 104. 36–44. 50 indexed citations
10.
Bai, Xueqin, Juan Peng, Meimei Wang, et al.. (2018). PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?. Clinica Chimica Acta. 483. 192–196. 22 indexed citations
11.
Li, Qing, Chunyan Wu, Zhong Ren, et al.. (2017). Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives. Acta Pharmacologica Sinica. 38(3). 301–311. 20 indexed citations
12.
Tang, Zhi‐Han, Juan Peng, Zhong Ren, et al.. (2017). New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Atherosclerosis. 262. 113–122. 222 indexed citations
13.
Liu, Mi‐Hua, Yuan Zhang, Jun He, et al.. (2016). Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway. International Journal of Molecular Medicine. 37(6). 1661–1668. 33 indexed citations
14.
Wu, Qi, Juan Peng, Lihong Pan, et al.. (2016). Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(−/−) mice may be associated with increased PCSK9 expression. Molecular Medicine Reports. 15(2). 712–718. 39 indexed citations
15.
Liu, Mi‐Hua, Guohua Li, Lijun Peng, et al.. (2016). PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cells. Molecular and Cellular Biochemistry. 414(1-2). 57–66. 29 indexed citations
16.
Qu, Shun-Lin, Zhi‐Han Tang, Yuan Zhang, et al.. (2014). SIRT1 in cardiovascular aging. Clinica Chimica Acta. 437. 106–114. 65 indexed citations
17.
Tang, Zhi‐Han, Zhong Ren, Xing Liu, et al.. (2013). Hydrogen sulfide prevents H2O2-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Molecular Medicine Reports. 7(6). 1865–1870. 76 indexed citations
18.
Liu, Mi‐Hua, Zhi‐Han Tang, Guohua Li, et al.. (2013). Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: Atherogenesis and angiogenesis. Atherosclerosis. 229(1). 10–17. 23 indexed citations
19.
Tang, Zhi‐Han, Lu Jiang, Juan Peng, et al.. (2012). PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages. International Journal of Molecular Medicine. 30(4). 931–938. 178 indexed citations
20.
Liu, Lu-Shan, Min Xie, Zhisheng Jiang, et al.. (2009). Effects of <I>pcsk9</I> siRNA on THP-1 Derived Macrophages Apoptosis Induced by oxLDL*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 36(3). 323–330. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Féliers Breakdown of academic impact, for papers by Zhisheng Jiang Breakdown of academic impact, for papers by Alexander Akhmedov Breakdown of academic impact, for papers by Dongming Su Breakdown of academic impact, for papers by Stephen L. Pinkosky Breakdown of academic impact, for papers by Kazuhiro Sonoda Breakdown of academic impact, for papers by Jun Kusunoki Breakdown of academic impact, for papers by Eseng Lai Breakdown of academic impact, for papers by David G. Hassall Breakdown of academic impact, for papers by Lushan Liu
Rankless by CCL
2026